Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

Rare spinal cancer tumor removed through patient’s eye at university hospital Patient is now ‘doing well,’ says she is ‘grateful’ to doctors. By Melissa Rudy Fox News.

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case ...

Just days after Lydia Dutcher gave birth to her son Theo, she learned she had a tumor in her placenta and was diagnosed with a rare form of cancer, choriocarcinoma, which could have spread to her ...

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - January 13, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor ...

The actress's tumor was found to be benign. "Grey's Anatomy" star Kate Walsh recalled the "very subtle" symptoms she experienced before she was diagnosed with a brain tumor in 2015.

Karla Flores had a tumor strangling her spinal cord near the base of her skull. Doctors weighed whether they should attempt a risky surgery that had never been done before.

A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free immunotherapy treatment in cancer patients. Biobatteries have the same basic ...

The FDA approved Adaptimmune Therapeutics’ Tecelra as a treatment for advanced cases of synovial sarcoma. It’s the first engineered cell therapy approved for treating a solid tumor.

Chicago man who survived brain tumor dies trying to scale Mount Makalu 03:07. An American climber died attempting to scale the world's fifth-highest mountain, Makalu, in the Himalayas, his ...

Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...

Adaptimmune Therapeutics plc, a company working to redefine the treatment of solid tumor cancers with cell therapy, today announced that letetresgene autoleucel, has been granted breakthrough ...